ResearchDefining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease
Jul 29, 2025Journal ArticleIntegrating hepatology with addiction care for inpatients with alcohol use disorder reduces future liver-related events.Written by 1 Roon author & 8 others Via Hepatology Communications
ResearchGlycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in citrin deficiency
ResearchProteomics identifies complement protein signatures in patients with alcohol-associated hepatitis
ResearchCytosolic calcium regulates hepatic mitochondrial oxidation, intrahepatic lipolysis, and gluconeogenesis via CAMKII activation
ResearchPrevalence and Clinical Correlation of Cardiometabolic Risk Factors in Alcohol-Related Liver Disease and Metabolic Dysfunction and Alcohol Associated Liver Disease (MetALD)
ResearchSerum Fibroblast Growth Factor-21 Discriminates Between Decompensated Alcohol-Associated Cirrhosis and Severe Alcohol-Associated Hepatitis
ResearchIntegrated hepatology and addiction care for inpatients with alcohol use disorder improves outcomes: a prospective study
ResearchModerate-high intensity exercise associates with reduced incident alcohol-associated liver disease in high-risk patients
ResearchCreation of an Inpatient Alcohol Liver Service Improves Early Liver Disease Detection in Patients With Alcohol Use Disorder
ResearchSubstance use disorder is associated with alcohol-associated liver disease in patients with alcohol use disorder